Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT

References

Page 1

	Year	Citations
1994 Consensus Conference on Acute GVHD Grading. Donna Przepiorka, Daniel Weisdorf, Peyton Martin, PubMed	1995	5.1K
Bone marrow transplant The Medical Journal of Australia TransplantationMarrow TransplantationBone Marrow FailureBone Marrow TransplantStem Cell Transplantation	1999	3.4K
Defining the Intensity of Conditioning Regimens: Working Definitions Andrea Bacigalupo, Karen K. Ballen, Doug Rizzo, Biology of Blood and Marrow Transplantation	2009	1.7K
A tutorial on propensity score estimation for multiple treatments using generalized boosted models Daniel F. McCaffrey, Beth Ann Griffin, Daniel Almirall, Statistics in Medicine	2013	1.4K
HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry Loren Gragert, Mary Eapen, Eric Williams, New England Journal of Medicine	2014	1.1K
Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors Claudio Anasetti, Brent R. Logan, Stephanie J. Lee, New England Journal of Medicine	2012	882
Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome Brian McClune, Daniel J. Weisdorf, Tanya L. Pedersen, Journal of Clinical Oncology Hematological MalignancyFirst Complete RemissionChronic GvhdTransplantationMarrow Transplantation	2010	477
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report Bone Marrow Transplantation Regenerative MedicineTransplantationMarrow TransplantationStem Cell TransplantationHematology	2017	384
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States Lori Muffly, Marcelo C. Pasquini, Michael J. Martens, Blood	2017	281
Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong, Journal of Clinical Oncology	2014	271

Page 1